New eye drops aim to restore feeling and healing in damaged corneas

NCT ID NCT07568730

Recruiting now Symptom relief Sponsor: TearSolutions, Inc. Source: ClinicalTrials.gov ↗

First seen May 07, 2026 · Last updated May 07, 2026

Summary

This study tests an eye drop called Lacripep in 54 adults with neurotrophic keratitis, a condition where the cornea loses feeling and cannot heal properly. The goal is to see if the drops safely improve corneal healing, restore some sensation, and improve quality of life. Participants will be randomly assigned to receive either the active drops or a placebo for several weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROTROPHIC KERATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Midwest Cornea Associates
RECRUITING

Carmel, Indiana, 46032, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Minnesota Eye Consultants
RECRUITING

Minneapolis, Minnesota, 55431, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Ophthalmology Associates
NOT_YET_RECRUITING

St Louis, Missouri, 63131, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEUROTROPHIC KERATITIS